MetLife, Inc.
MET
$97.66
$0.190.20%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.44% | 7.72% | 8.45% | 2.80% | 1.86% |
| Total Other Revenue | -51.94% | -62.21% | 19.12% | -72.73% | 304.02% |
| Total Revenue | 8.75% | 5.57% | 8.59% | 0.83% | 6.18% |
| Cost of Revenue | 11.35% | 8.47% | 10.50% | 2.59% | 1.60% |
| Gross Profit | 1.25% | -2.78% | 2.77% | -4.29% | 22.06% |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 12.21% | 9.24% | 6.83% | 4.61% | 3.24% |
| Total Operating Expenses | 11.51% | 8.61% | 9.83% | 2.96% | 1.89% |
| Operating Income | -19.28% | -24.09% | -6.01% | -21.12% | 85.35% |
| Income Before Tax | -14.71% | -18.83% | -17.09% | -4.96% | 53.39% |
| Income Tax Expenses | -14.06% | -15.08% | 6.79% | -24.02% | 79.36% |
| Earnings from Continuing Operations | -14.93% | -20.00% | -23.42% | 2.09% | 46.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -135.71% | 126.67% | -33.33% | 0.00% | 50.00% |
| Net Income | -15.42% | -19.65% | -23.66% | 2.10% | 47.37% |
| EBIT | -19.28% | -24.09% | -6.01% | -21.12% | 85.35% |
| EBITDA | -16.66% | -21.30% | -4.70% | -19.16% | 70.73% |
| EPS Basic | -11.47% | -15.87% | -20.99% | 7.16% | 59.31% |
| Normalized Basic EPS | -10.89% | -13.97% | -13.03% | -0.10% | 63.17% |
| EPS Diluted | -11.49% | -15.95% | -21.13% | 7.18% | 59.31% |
| Normalized Diluted EPS | -10.85% | -13.93% | -13.03% | -0.13% | 63.13% |
| Average Basic Shares Outstanding | -4.66% | -5.01% | -5.31% | -5.60% | -6.10% |
| Average Diluted Shares Outstanding | -4.69% | -5.04% | -5.32% | -5.58% | -6.06% |
| Dividend Per Share | 4.20% | 4.15% | 4.32% | 4.48% | 4.66% |
| Payout Ratio | 0.16% | 0.21% | 0.29% | -0.04% | -0.33% |